Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Treating Pediatric Sleep Apnea Requires Combined Methods

By HospiMedica staff writers
Posted on 24 Jul 2008
Treating pediatric obstructive sleep apnea (OSA) with either orthodontic expansion or adenotonsillectomy improves symptoms, but most young children need both treatments to have complete resolution of OSA symptoms, claims a new study.

Researchers at Stanford University School of Medicine (Palo Alto, CA, USA) conducted a study of 32 children between the ages of five and nine who were referred for treatment of symptoms such as snoring, disrupted sleep, daytime fatigue and abnormal amounts of movement during sleep. More...
Participants were enrolled in the study after OSA was confirmed by overnight polysomnography, and after clinical evaluations determined that both treatments would be needed. Half of the children were treated first with adenotonsillectomy performed by an otolaryngologist, and half were treated first with orthodontic expansion using an appliance designed to be fixed to the teeth. After treatment, each child was monitored again by overnight polysomnography and evaluated in the clinic three to six months later. The children were then treated with the second method followed by another polysomnogram and clinical evaluation, except for two children whose symptoms resolved after orthodontic expansion alone.

The study results showed that in all participants symptoms improved but were not normalized, with no significant difference in the two treatment groups. All 32 children showed improvements after being treated with either oradenotonsillectomy or orthodontic expansion, but 28 of the participants needed both treatments for the symptoms of OSA to be eliminated. Two children had no more symptoms after being treated only with orthodontic expansion, and two other children continued to have symptoms after both treatments. The study was published in the July 1, 2008, issue of the journal Sleep.

"Usually physicians treat OSA by taking tonsils and adenoids out,” said lead author Professor Christian Guilleminault, M.D, a specialist in sleep medicine. "Often the upper airway is small due to the bones that make up the facial structure; this in itself limits the benefits of surgical elimination of tonsils and adenoids. The combination of two treatments - one of them is a special type of orthodontic treatment - will give better results than elimination of tonsils and adenoids alone.”

Pediatric OSA is a common form of sleep-disordered breathing that affects about two percent of young children; it often appears between the ages of three and six years when the tonsils and adenoids are large compared to the throat. OSA occurs when muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway.


Related Links:
Stanford University School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.